161 related articles for article (PubMed ID: 36970071)
1. Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer.
Carbonnier V; Le Naour J; Bachelot T; Vacchelli E; André F; Delaloge S; Kroemer G
Oncoimmunology; 2023; 12(1):2189823. PubMed ID: 36970071
[TBL] [Abstract][Full Text] [Related]
2. No impact of cancer and plague-relevant
Petrazzuolo A; Le Naour J; Vacchelli E; Gaussem P; Ellouze S; Jourdi G; Solary E; Fontenay M; Smadja DM; Kroemer G
Oncoimmunology; 2020 Dec; 9(1):1857112. PubMed ID: 33344044
[TBL] [Abstract][Full Text] [Related]
3. An independent predictor of poor prognosis in locally advanced rectal cancer: rs867228 in formyl peptide receptor 1 (FPR1).
Chiang SF; Huang KC; Chen WT; Chen TW; Ke TW; Chao KSC
Oncoimmunology; 2021 May; 10(1):1926074. PubMed ID: 34026338
[TBL] [Abstract][Full Text] [Related]
4. Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis.
Le Naour J; Montégut L; Pan Y; Scuderi SA; Cordier P; Joseph A; Sauvat A; Iebba V; Paillet J; Ferrere G; Brechard L; Mulot C; Dubourg G; Zitvogel L; Pol JG; Vacchelli E; Puig PL; Kroemer G
Oncoimmunology; 2023; 12(1):2237354. PubMed ID: 37492227
[TBL] [Abstract][Full Text] [Related]
5. V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins.
Zhou C; Zhou Y; Wang J; Feng Y; Wang H; Xue J; Chen Y; Ye RD; Wang MW
Biochem J; 2013 Apr; 451(2):245-55. PubMed ID: 23373827
[TBL] [Abstract][Full Text] [Related]
6. A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency.
Le Naour J; Liu P; Zhao L; Adjemian S; Sztupinszki Z; Taieb J; Mulot C; Silvin A; Dutertre CA; Ginhoux F; Sauvat A; Cerrato G; Castoldi F; Martins I; Stoll G; Paillet J; Mangane K; Richter C; Kepp O; Maiuri MC; Pietrocola F; Vandenabeele P; André F; Delaloge S; Szallasi Z; Laurent-Puig P; Zucman-Rossi J; Zitvogel L; Pol JG; Vacchelli E; Kroemer G
Cancer Discov; 2021 Feb; 11(2):408-423. PubMed ID: 33046534
[TBL] [Abstract][Full Text] [Related]
7. Human formyl peptide receptor 1 (FPR1) c.32C>T SNP is associated with decreased soluble E-selectin levels.
Benachour H; Zaiou M; Herbeth B; Lambert D; Lamont JV; Pfister M; Siest G; Tiret L; Blankenberg S; Fitzgerald PS; Visvikis-Siest S
Pharmacogenomics; 2009 Jun; 10(6):951-9. PubMed ID: 19530962
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the formylpeptide receptor gene (FPR1) and susceptibility to stomach cancer in 1531 consecutive autopsy cases.
Otani T; Ikeda S; Lwin H; Arai T; Muramatsu M; Sawabe M
Biochem Biophys Res Commun; 2011 Feb; 405(3):356-61. PubMed ID: 21216225
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer metastasis to brain results in recruitment and activation of microglia through annexin-A1/formyl peptide receptor signaling.
Foo SL; Sachaphibulkij K; Lee CLY; Yap GLR; Cui J; Arumugam T; Lim LHK
Breast Cancer Res; 2022 Apr; 24(1):25. PubMed ID: 35382852
[TBL] [Abstract][Full Text] [Related]
10. Formylpeptide receptor single nucleotide polymorphism 348T>C and its relationship to polymorphonuclear leukocyte chemotaxis in aggressive periodontitis.
Maney P; Walters JD
J Periodontol; 2009 Sep; 80(9):1498-505. PubMed ID: 19722801
[TBL] [Abstract][Full Text] [Related]
11. FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy.
Liang XY; Chen LJ; Ng TK; Tuo J; Gao JL; Tam PO; Lai TY; Chan CC; Pang CP
Eye (Lond); 2014 Dec; 28(12):1502-10. PubMed ID: 25277308
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.
Vacchelli E; Ma Y; Baracco EE; Sistigu A; Enot DP; Pietrocola F; Yang H; Adjemian S; Chaba K; Semeraro M; Signore M; De Ninno A; Lucarini V; Peschiaroli F; Businaro L; Gerardino A; Manic G; Ulas T; Günther P; Schultze JL; Kepp O; Stoll G; Lefebvre C; Mulot C; Castoldi F; Rusakiewicz S; Ladoire S; Apetoh L; Bravo-San Pedro JM; Lucattelli M; Delarasse C; Boige V; Ducreux M; Delaloge S; Borg C; André F; Schiavoni G; Vitale I; Laurent-Puig P; Mattei F; Zitvogel L; Kroemer G
Science; 2015 Nov; 350(6263):972-8. PubMed ID: 26516201
[TBL] [Abstract][Full Text] [Related]
13. A major genetic accelerator of cancer diagnosis: rs867228 in FPR1.
Sztupinszki Z; Le Naour J; Vacchelli E; Laurent-Puig P; Delaloge S; Szallasi Z; Kroemer G
Oncoimmunology; 2021 Jan; 10(1):1859064. PubMed ID: 33489470
[No Abstract] [Full Text] [Related]
14. Human formyl peptide receptor 1 C32T SNP interacts with age and is associated with blood pressure levels.
El Shamieh S; Herbeth B; Azimi-Nezhad M; Benachour H; Masson C; Visvikis-Siest S
Clin Chim Acta; 2012 Jan; 413(1-2):34-8. PubMed ID: 21144844
[TBL] [Abstract][Full Text] [Related]
15. Regulation of human formyl peptide receptor 1 synthesis: role of single nucleotide polymorphisms, transcription factors, and inflammatory mediators.
Miettinen HM
PLoS One; 2011; 6(12):e28712. PubMed ID: 22174875
[TBL] [Abstract][Full Text] [Related]
16. Probiotic Lactobacillus rhamnosus GG (LGG) restrains the angiogenic potential of colorectal carcinoma cells by activating a proresolving program via formyl peptide receptor 1.
Liotti F; Marotta M; Sorriento D; Pagliuca C; Caturano V; Mantova G; Scaglione E; Salvatore P; Melillo RM; Prevete N
Mol Oncol; 2022 Aug; 16(16):2959-2980. PubMed ID: 35808840
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil formylpeptide receptor single nucleotide polymorphism 348T>C in aggressive periodontitis.
Maney P; Emecen P; Mills JS; Walters JD
J Periodontol; 2009 Mar; 80(3):492-8. PubMed ID: 19254133
[TBL] [Abstract][Full Text] [Related]
18. [Study of the association between polymorphism of persistent obesity, human leptin gene/leptin receptor gene and molecular subtypes of breast cancer].
Yuan XL; Xu ZP; Liu CR; Yan LP; Tao P; Xiong P; Li Q; Zhou M; Li H; Zhao M; Li JY
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):533-538. PubMed ID: 28592099
[No Abstract] [Full Text] [Related]
19. Annexin A1 and its receptor gene polymorphisms in systemic lupus erythematosus in the Tunisian population.
Dhaffouli F; Hachicha H; Abida O; Gharbi N; Elloumi N; Kanoun H; Belguith N; Marzouk S; Fakhfakh R; Sawsen F; Mnif H; Kamoun H; Bahloul Z; Masmoudi H
Clin Rheumatol; 2022 May; 41(5):1359-1369. PubMed ID: 35028743
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion.
Minopoli M; Botti G; Gigantino V; Ragone C; Sarno S; Motti ML; Scognamiglio G; Greggi S; Scaffa C; Roca MS; Stoppelli MP; Ciliberto G; Losito NS; Carriero MV
J Exp Clin Cancer Res; 2019 Nov; 38(1):459. PubMed ID: 31703596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
